Trovan
Company: Pfizer
Approval Status: Approved December 1997
Treatment for: bacterial infections
Areas: Immunology/Infectious Diseases; Pharmacology/Toxicology
| General Information | Mechanism of Action |
General Information
Other Useful Resources
Trovan (trovafloxacin), a broad-spectrum antibiotic, has been approved for the treatment of 14 bacterial infections.
Mechanism of Action
Trovan is a member of the quinolone class of antibiotics.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
